AIDS Reviews

Aims & Scope

AIDS Reviews publishes papers reporting original scientific, clinical, epidemiologic and social research which contribute to the overall knowledge of the field of the acquired immunodeficiency syndrome and human retrovirology.

Currently, the Journal publishes review articles (usually by invitation, but spontaneous submitted articles will also be considered).

Manuscripts submitted to AIDS Reviews will be accepted on the understanding that the authors have not submitted the paper to another journal or published the material elsewhere.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.5
2024	1.90

SJR (SCImago Journal Rank)

Year	Value
2024	0.491

Quartile

Year	Value
2024	Q3

Journal Rank

Year	Value
2024	11773

Journal Citation Indicator

Year	Value
2024	108

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Neuropsychiatric Adverse Events with Dolutegravir and Other Integrase Strand Transfer Inhibitors

  Citation: 90

  Authors: Christian, Josep M.

• The Importance of Understanding the Stages of COVID-19 in Treatment and Trials

  Citation: 77

  Authors: Daniel O., Denise, Binh, Pierre, Marco, Leland, Jose, Michael, Neha, Gino K., Daniel, Preet, Vito M., Diana L., David, Glenn, David, Miroslaw, April, Eivind H., Rajkumar, Fred R., Cristina, Oriol, Vicente, Nicolas, Gilles, Maria Carmela, António, Iraldo B., Ivan F. H., Marc, Stephen, Joseph, Paul

• The Risk and Impact of COVID-19 Pandemic on Immunosuppressed Patients: Cancer, HIV, and Solid Organ Transplant Recipients

  Citation: 46

  Authors: Ali Haider, Ali, Juman, Bassam A.

• HIV and HCV in U.S. Prisons and Jails: The Correctional Facility as a Bellwether Over Time for the Community’s Infections

  Citation: 37

  Authors: Anne C., Emeli J., Mohammed A., Cesar A., Jennifer A.

• Beyond Pegylated Interferon-Alpha: New Treatments for Hepatitis Delta

  Citation: 28

  Authors: Katja, Heiner

• Report from the International Conference on Viral Hepatitis (ICVH) – Chicago, October 2017

  Citation: 23

  Authors: Vicente, Benjamin, Nancy

• Oral antivirals for the prevention and treatment of SARS-CoV-2 infection

  Citation: 20

  Authors: Vicente, Carmen, Benson, Ana, Pablo, José V., Howard E.

• Mobile applications in HIV self-management: A systematic review of scientific literature

  Citation: 18

  Authors: Esmaeil, SeyedAhmad, Zahra, Pegah, Alireza, Farzin, Kowsar, Marcarious M., Zahra, Amirali, Mohammad, Mohammad

• Differential Contribution of HIV-1 Subtypes B and C to Neurological Disorders: Mechanisms and Possible Treatments

  Citation: 17

  Authors: Maryline, Ying, Sterling, Charles, Bassel E.

• HIV Treatment Adherence - A Shared Burden for Patients, Health-Care Providers, and Other Stakeholders

  Citation: 17

  Authors: Surajudeen A., Kurubaran, Lekhraj, Olutayo F.

---